AV
Annika Valla Broman
About Annika Valla Broman
Data last updated:
Annika Valla Broman is a Director at Novo Nordisk India Private Limited (since 2025). The company operates in Healthcare. Novo Nordisk India Private Limited reported revenue of ₹3,333 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Sep 2025 | 1994 | ₹3,333 Cr (FY 2025) | Active |
Board colleagues of Annika Valla Broman
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Kumar Das | 10362944 | Novo Nordisk India Private Limited | Whole-Time Director |
| Juhi Pant | Novo Nordisk India Private Limited | Company Secretary | |
| Nanna Liborius Sjoerup | 11142262 | Novo Nordisk India Private Limited | Director |
| Thyagarajan Jayagovindan | 11142202 | Novo Nordisk India Private Limited | Director |
| Vikrant Shrotriya | 08635146 | Novo Nordisk India Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Annika Valla Broman
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Annika Valla Broman
Annika Valla Broman currently holds 1 directorship: Novo Nordisk India Private Limited (Director, since 22 Sep 2025, revenue ₹3,333 Cr (FY 2025)).
Annika Valla Broman was first appointed on 22 Sep 2025 as Director at Novo Nordisk India Private Limited.
The current boards of Annika Valla Broman's companies include Amit Kumar Das (Novo Nordisk India Private Limited), Juhi Pant (Novo Nordisk India Private Limited), Nanna Liborius Sjoerup (Novo Nordisk India Private Limited), Thyagarajan Jayagovindan (Novo Nordisk India Private Limited), Vikrant Shrotriya (Novo Nordisk India Private Limited).